Dr. Michael Kastenberger
About Dr. Michael Kastenberger
Dr. Michael Kastenberger is a Clinical Trial Manager at Bristol-Myers Squibb in München, Germany, with extensive experience in managing clinical trials in cardiology, rheumatology, and oncology. He holds a Dr. rer. nat. in molecular oncology from Universitätsklinikum Regensburg and a Diplom-Biologe degree from Universität Regensburg.
Title
Dr. Michael Kastenberger holds the title of Clinical Trial Manager. He has occupied this role at Bristol-Myers Squibb since June 2018, focusing on overseeing clinical trials in the areas of cardiology, rheumatology, and oncology.
Company
Currently, Dr. Michael Kastenberger is employed at Bristol-Myers Squibb, a biopharmaceutical company, where he serves as the Clinical Trial Manager. His tenure at the company began in June 2018 and he is located in München und Umgebung, Deutschland.
Education and Expertise
Dr. Michael Kastenberger completed his doctoral studies (Dr. rer. nat.) in Molecular Oncology at Universitätsklinikum Regensburg from 2007 to 2010. Prior to that, he studied Biology at Universität Regensburg, graduating with a Diplom-Biologe degree in 2006. His academic background laid a strong foundation in molecular biology, oncology, and biology.
Previous Roles
Before his current role, Dr. Michael Kastenberger worked as a Senior Clinical Research Associate at Servier Forschung und Pharma-Entwicklung GmbH for six years (2012-2018) in München und Umgebung, Deutschland. He also held a position as a Biologe im Biotechnologiebreich at Profos AG for 3 months in 2006, and completed multiple internships at Geneart AG, Profos AG, and the Research School for Biological Science in 2003 and 2004.